Gonadorelin is a synthetic peptide identical to gonadotropin-releasing hormone (GnRH), the master hormone that controls testosterone and fertility hormone production. Unlike most hormonal interventions, gonadorelin's effectiveness depends critically on how it's administered—pulsatile dosing (mimicking the body's natural rhythm) maintains hormonal benefits, while continuous dosing causes the opposite effect through receptor downregulation.
This guide focuses on practical dosing protocols, administration methods, and timing strategies based on clinical evidence and therapeutic use cases.
Injection (Subcutaneous or Intramuscular)
Standard dose: 100–250 mcg twice weekly
Typical schedule: Monday and Thursday (or any 3–4 day spacing)
Route: Subcutaneous injection (most common) or intramuscular
Cost: $40–$120 per month
This is the most common protocol for maintaining testicular function in men on testosterone replacement therapy (TRT) or treating hypogonadotropic hypogonadism. The twice-weekly dosing mimics a pulsatile pattern, stimulating luteinizing hormone (LH) and follicle-stimulating hormone (FSH) release without causing receptor downregulation.
Typical injection protocol:
- Week 1–52+: 100–250 mcg intramuscularly or subcutaneously on Monday
- Week 1–52+: 100–250 mcg intramuscularly or subcutaneously on Thursday
Doses at the lower end (100 mcg) are used for maintenance, while doses toward the upper range (200–250 mcg) are used for therapeutic intervention or fertility restoration.
Nasal (Pulsatile Intranasal)
Standard dose: 400–800 mcg three times daily
Schedule: Morning, afternoon, and evening (approximately 4–6 hours apart)
Cost: $40–$120 per month
Nasal administration is less common in current practice but remains the gold standard for pulsatile dosing, as it more closely mimics the body's natural GnRH pulse frequency. This route is typically reserved for specialized fertility clinics or hypogonadism management.
Typical nasal protocol:
- 8:00 AM: 400–800 mcg nasal spray
- 2:00 PM: 400–800 mcg nasal spray
- 8:00 PM: 400–800 mcg nasal spray
Goal 1: Maintain Testicular Function During TRT (Most Common Use)
Dose: 100–150 mcg twice weekly
Schedule: Monday and Thursday
Rationale: Men on exogenous testosterone suppress endogenous LH, which causes testicular atrophy and infertility. Gonadorelin prevents this by maintaining pulsatile LH signaling.
Protocol:
- Start at 100 mcg twice weekly
- Assess after 8–12 weeks (testicular volume, sperm count if fertility is a goal)
- Adjust to 150 mcg twice weekly if testicular atrophy continues
Goal 2: Restore Fertility in Hypogonadotropic Hypogonadism
Dose: 200–250 mcg twice weekly (injection) OR 400–800 mcg three times daily (nasal)
Duration: 12–24 weeks for spermatogenesis restoration
Rationale: Higher doses and more frequent administration maximize LH and FSH stimulation to restart sperm production.
Protocol:
- Start with 200 mcg twice weekly (injection) or 800 mcg three times daily (nasal)
- Maintain for 12–24 weeks
- Monitor semen analysis at 8, 12, and 16 weeks
- Clinical data shows 90% of patients achieve spermatogenesis within 6 months using pulsatile administration
Goal 3: Diagnostic Assessment (Clinical Use)
Dose: Single 100 mcg dose
Schedule: One-time administration
Rationale: Clinicians use a single gonadorelin dose to assess hypothalamic-pituitary function by measuring LH and FSH response.
This is not a chronic dosing protocol and is used exclusively in medical diagnostic settings.
Subcutaneous Injection
- Reconstitution: Mix gonadorelin powder with bacteriostatic water (typically 1 mL per vial) per manufacturer instructions
- Preparation: Draw 100–250 mcg into an insulin syringe (28–31 gauge)
- Site selection: Rotate injection sites (abdomen, thighs, upper arms) to minimize tissue irritation
- Injection: Insert needle at 45–90° angle, inject subcutaneously, and withdraw needle
- Timing: Inject at consistent times on dosing days (e.g., 8:00 AM Monday and Thursday)
Common side effects at injection site: Mild redness, swelling, or discomfort (most frequent adverse effect)
Intramuscular Injection
- Reconstitution: Same as subcutaneous
- Site selection: Gluteus maximus (upper outer quadrant) or deltoid muscle
- Injection: Insert needle perpendicular to skin, inject intramuscularly
- Advantages over subcutaneous: Potentially faster absorption, less local irritation for some users
Nasal Administration
- Preparation: Ensure nasal passages are clear
- Dosing: Spray 400–800 mcg into one nostril per dose
- Timing: Administer three times daily with 4–6 hour spacing
- Important: Avoid eating or drinking for 15 minutes after administration to maximize absorption
Year-Round Protocol (TRT Maintenance)
For men on testosterone replacement, gonadorelin is typically administered year-round without cycling:
- 100 mcg Monday
- 100 mcg Thursday
- Repeat continuously
This prevents testicular atrophy and maintains endogenous testosterone production baseline during chronic exogenous testosterone use.
Fertility-Focused Protocol (Seasonal/Cyclical)
For patients pursuing fertility restoration, a 12–24 week intensive cycle is standard:
- Weeks 1–24: 200–250 mcg twice weekly (or 800 mcg nasal three times daily)
- Weeks 25–52: Taper to maintenance dose (100 mcg twice weekly) or discontinue if fertility goals achieved
- Monitor: Semen analysis every 4–6 weeks during treatment phase
Spacing Considerations
- Minimum spacing: 3 days between doses (e.g., Monday/Thursday works; Tuesday/Friday also acceptable)
- Maximum spacing: Do not exceed 5 days between doses, as this risks loss of pulsatile signaling
- Consistency: Maintain the same day-of-week schedule to establish predictable hormone rhythm
Beginner Protocol (First-Time Users)
Objective: Achieve hormonal benefit while minimizing side effects
Recommended approach:
- Start at 100 mcg twice weekly via subcutaneous injection
- Choose Monday/Thursday schedule for simplicity
- Maintain for 8–12 weeks before dose adjustment
- Monitor: Testosterone, LH, FSH at baseline and week 8
- Side effects usually resolve within 2–4 weeks (transient flushing, mild headache)
Rationale: Lower starting dose reduces risk of adverse effects while establishing tolerance. Most men achieve target testosterone levels and testicular function at this dose.
Advanced Protocol (Experienced Users or Specialized Goals)
Objective: Maximize fertility restoration or hormonal optimization
Recommended approach:
- Start at 200 mcg twice weekly or 800 mcg nasal three times daily
- If fertility is goal, use pulsatile nasal dosing for superior LH/FSH synchronization
- Combine with exogenous gonadotropins (FSH) if spermatogenesis is not achieved within 12 weeks
- Monitor: Semen analysis (count, motility, morphology) every 4 weeks
Rationale: Higher frequencies and doses maximize gonadotropin secretion for expedited fertility restoration. Clinical evidence shows 90% achieve spermatogenesis within 6 months using this approach, compared to 14 months with cyclical gonadotropin therapy alone.
Mistake 1: Continuous Dosing (Non-Pulsatile)
Error: Administering gonadorelin as a constant infusion or daily injection without pulsatile spacing
Consequence: Receptor downregulation, suppressed LH/FSH, and complete opposite of intended effect (hypogonadism instead of restoration)
Prevention: Always use twice-weekly spacing (injection) or three-times-daily spacing (nasal) with 4–6 hour intervals
Mistake 2: Inadequate Dose for Fertility Goals
Error: Using 100 mcg twice weekly when attempting to restore fertility
Consequence: Suboptimal LH/FSH stimulus; spermatogenesis may not initiate or progresses slowly
Prevention: Use 200–250 mcg twice weekly or 800 mcg nasal three times daily for fertility restoration; reserve 100 mcg dosing for maintenance during TRT
Mistake 3: Inconsistent Timing
Error: Varying injection days significantly (e.g., Monday one week, Wednesday the next)
Consequence: Loss of predictable pulsatile signaling; reduced efficacy
Prevention: Pick two specific days (Monday/Thursday recommended) and maintain indefinitely
Mistake 4: Rapid Dose Escalation
Error: Increasing dose every week or switching protocols without 8–12 week observation period
Consequence: Inability to identify which dose produced desired effects; difficulty managing side effects
Prevention: Commit to starting dose for minimum 8–12 weeks before adjusting
Mistake 5: Mixing Administration Routes Without Guidance
Error: Switching between subcutaneous and intramuscular or nasal to injection without medical supervision
Consequence: Unpredictable absorption and hormone levels
Prevention: Choose one route and maintain it; changes require physician guidance and monitoring
| Goal | Dose | Frequency | Schedule | Route | Duration |
|---|
| TRT Maintenance | 100 mcg | 2x weekly | Mon/Thu | SubQ | Indefinite |
| Fertility Restoration | 200–250 mcg | 2x weekly | Mon/Thu | SubQ/IM | 12–24 weeks |
| Fertility (Pulsatile) | 800 mcg | 3x daily | 4–6 hr intervals | Nasal | 12–24 weeks |
| Diagnostic | 100 mcg | Single dose | Once | SubQ | N/A |
| TRT + Advanced | 150 mcg | 2x weekly | Mon/Thu | SubQ | Indefinite |
| Beginner TRT | 100 mcg | 2x weekly | Mon/Thu | SubQ | Indefinite |
Monthly cost: $40–$120 (compounded pharmaceutical, prescription required in most jurisdictions)
Per-dose cost: Approximately $2.50–$6 per injection at standard dosing rates
Prescription requirement: Gonadorelin is a prescription medication; compounded versions are widely available in the United States but require a valid prescription from a licensed physician
Storage: Reconstituted gonadorelin should be stored according to manufacturer guidelines; most remain stable for 30 days refrigerated at 2–8°C
- Pulsatile is essential: Twice-weekly or three-times-daily spacing maintains receptor sensitivity; continuous dosing causes receptor downregulation
- Start low and stabilize: Begin at 100 mcg twice weekly; adjust only after 8–12 weeks
- Match dose to goal: Maintenance requires lower doses (100 mcg); fertility restoration requires higher doses (200–250 mcg)
- Choose one route: Subcutaneous is most practical for long-term use; nasal is superior for pulsatile mimicry
- Consistency matters: Maintain the same injection days and times to establish predictable hormone rhythm
- Monitor and adjust: Baseline and periodic labs (testosterone, LH, FSH, or semen analysis) guide dose optimization
This guide is educational content only and does not constitute medical advice. Gonadorelin is a prescription medication requiring supervision by a licensed healthcare provider. Dosing protocols, monitoring intervals, and safety assessments should be individualized based on your specific clinical situation, laboratory values, and health history. Always consult a physician before starting or modifying gonadorelin dosing. The information presented reflects clinical evidence and therapeutic use cases but does not replace professional medical judgment.